‘We’re flying blind’: Study calls for disaggregated health data A global analysis has highlighted a need for better data to address hidden inequities. But a GP expert is concerned about further bias.
In Practice: Changes to dual-labelled medicine ingredient names The TGA has advised that more dual-labelled medicine ingredient names have begun the transition to sole ingredient names.
Diabetes prevalence underestimated in Australia: Study Researchers have suggested the number of people living with diabetes could be more than a third higher than officially registered.
Expanded PBS listing for empagliflozin An RACGP expert describes the change as a ‘double win’, with the 1 April expansion to benefit more patients with type 2 diabetes.
One in 15 Australian adults living with diabetes: ABS Around 6.6% of adults now have diabetes, up from 5.1% a decade earlier, according to new data.
‘Stopping antidepressants or not?’ New research says collaborative primary care planning between GPs and patients is key to decisions around prescribing and cessation.
Novel blood test predicts kidney disease A blood test for detecting risk of developing diabetic kidney disease is now available in Australia, but a GP expert raises some concerns.
Exploring the benefits of CGM in type 2 diabetes SPONSORED: An expanding evidence-base is creating a compelling rationale for increased use of continuous glucose monitoring.
‘A wake-up call’: GPs issued warning over semaglutide prescribing The DoHAC has delivered ‘education letters’ to more than 1000 doctors found to be prescribing the medication under the PBS, but failing to follow the criteria.
TGA approves HRT patch alternatives The ongoing short supply of hormone replacement therapy patches has resulted in the approval of a range of overseas alternatives.